This shows you the differences between two versions of the page.
| Next revision | Previous revision | ||
| ctd_testing [2026/09/23 15:53] – created admin | ctd_testing [2026/09/23 16:16] (current) – admin | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ===== MDA5 ===== | + | ===== MDA5 and ASYS ===== |
| - | BLUF: lineblot is highly prone to FP and FN results. IP is best overall, but ELISA is a faster, acceptable non-IP alternative. | + | < |
| Modality ranked by highest to lower // | Modality ranked by highest to lower // | ||
| Line 11: | Line 11: | ||
| - ELISA >= IP >> multiplex bead assays >> lineblot | - ELISA >= IP >> multiplex bead assays >> lineblot | ||
| + | |||
| + | ==== Reliable test options ==== | ||
| + | |||
| + | < | ||
| + | |||
| + | ^ lab ^ test_name | ||
| + | |OMRF| Comprehensive Myositis Autoantibody Profile|https:// | ||
| + | | Labcorp | ||
| + | | Labcorp | ||
| + | |Quest|Myositis Specific 11 Antibodies Panel | https:// | ||
| + | |Quest|Extended Myositis Specific Antibody (MSA) Panel | https:// | ||
| + | |||